Publishing their results in The Lancet in December 1987, the investigators concluded 'Further studies in the insulinotropic action of GLP-1 7-36 in health and disease will be of great interest
The drug combination of GLP-1 RA and insulin to utilize both their merits (FBG: Fasting blood glucose
c , Top four cellular component and top nine biological process functional terms identified using gene set enrichment (GSEA) analysis
Eur J Endocrinol 183(5):R119R132 [DOI] [PMC free article] [PubMed] [Google Scholar] 41.Yamada C, Yamada Y, Tsukiyama K, Yamada K, Udagawa N, Takahashi N, Tanaka K, Drucker DJ, Seino Y, Inagaki N (2008) The murine glucagon-like peptide-1 receptor is essential for control of bone resorption
Essmann, U
What cardiovascular benefits do GLP-1 medications offer beyond weight loss